Jump Financial’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Jump Financial's BIIB Position: Q1 2026 in Review
Jump Financial sold out of Biogen (BIIB) in Q1 2026, closing a stake of 5,779 shares — an estimated $1.02M sold.
Jump Financial first reported a position in BIIB in Q2 2021 and held it in 15 quarters. The position peaked at $14.5M in Q4 2024. 1,011 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Jump Financial reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
- Jump Financial sold 5,779 Biogen shares in Q1 2026, an estimated $1.02M.
- Jump Financial first reported a position in Biogen in Q2 2021 and held it in 15 quarters.
- Jump Financial's Biogen position peaked at $14.5M in Q4 2024.
- 1,011 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.